Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Deborah Tweddle

Newcastle AuthorsTitleYearFull text
Dr Shelby Barnett
Dr Vickyanne Carruthers
Professor Deborah Tweddle
Professor Gareth Veal
Clinical pharmacology of cytotoxic drugs in neonates and infants: providing evidence-based dosing guidance2021
Dr Nicholas Bown
Professor Deborah Tweddle
Frequency and Prognostic Impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High Risk Neuroblastoma trial (HRNBL-1)2021
Harriet Southgate
Dr Lindi Chen
Professor Nicola Curtin
Professor Deborah Tweddle
Increased replication stress determines ATR inhibitor sensitivity in neuroblastoma cells2021
Professor Gareth Veal
Professor Deborah Tweddle
Julie Errington
Pharmacokinetics and safety of a novel oral liquid formulation of 13-cis retinoic acid in children with neuroblastoma: A randomized crossover clinical trial2021
Dr Shelby Barnett
Professor Deborah Tweddle
Professor Gareth Veal
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients2021
Dr Nicholas Bown
Professor John Lunec
Professor Deborah Tweddle
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group2020
Harriet Southgate
Dr Lindi Chen
Professor Deborah Tweddle
Professor Nicola Curtin
ATR inhibition potentiates parp inhibitor cytotoxicity in high risk neuroblastoma cell lines by multiple mechanisms2020
Swathi Merugu
Dr Lindi Chen
Elizabeth Gavens
Hany Gabra
Dr Al Gabriel
et al.
Detection of circulating and disseminated neuroblastoma cells using the Imagestream Imaging Flow Cytometer for use as predictive and pharmacodynamic biomarkers2020
Hannah Smith
Harriet Southgate
Professor Deborah Tweddle
Professor Nicola Curtin
DNA damage checkpoint kinases in cancer2020
Harriet Southgate
Dr Lindi Chen
Professor Nicola Curtin
Professor Deborah Tweddle
Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma2020
123456789